Cetera Investment Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
24,296
-4,959
| -17% | -$273K | ﹤0.01% | 2139 |
|
|
2025
Q1 | $2.07M | Buy |
29,255
+17,931
| +158% | +$1.27M | ﹤0.01% | 1726 |
|
|
2024
Q4 | $744K | Buy |
11,324
+3,870
| +52% | +$254K | ﹤0.01% | 2374 |
|
|
2024
Q3 | $524K | Sell |
7,454
-4,238
| -36% | -$298K | ﹤0.01% | 2611 |
|
|
2024
Q2 | $963K | Sell |
11,692
-4,357
| -27% | -$359K | ﹤0.01% | 2103 |
|
|
2024
Q1 | $1.4M | Buy |
16,049
+11,030
| +220% | +$963K | ﹤0.01% | 1806 |
|
|
2023
Q4 | $484K | Buy |
5,019
+194
| +4% | +$18.7K | ﹤0.01% | 1509 |
|
|
2023
Q3 | $427K | Buy |
4,825
+238
| +5% | +$21.1K | ﹤0.01% | 1508 |
|
|
2023
Q2 | $398K | Buy |
4,587
+1,057
| +30% | +$91.6K | ﹤0.01% | 1578 |
|
|
2023
Q1 | $343K | Buy |
3,530
+59
| +2% | +$5.74K | ﹤0.01% | 1628 |
|
|
2022
Q4 | $359K | Buy |
3,471
+371
| +12% | +$38.4K | ﹤0.01% | 1549 |
|
|
2022
Q3 | $263K | Sell |
3,100
-189
| -6% | -$16K | 0.01% | 1358 |
|
|
2022
Q2 | $273K | Sell |
3,289
-2,670
| -45% | -$222K | ﹤0.01% | 1481 |
|
|
2022
Q1 | $459K | Sell |
5,959
-511
| -8% | -$39.4K | 0.01% | 1217 |
|
|
2021
Q4 | $572K | Buy |
6,470
+370
| +6% | +$32.7K | 0.01% | 1105 |
|
|
2021
Q3 | $471K | Buy |
6,100
+483
| +9% | +$37.3K | 0.01% | 1178 |
|
|
2021
Q2 | $469K | Buy |
+5,617
| New | +$469K | 0.01% | 1154 |
|
|
2021
Q1 | – | Sell |
-2,695
| Closed | -$236K | – | 1600 |
|
|
2020
Q4 | $236K | Buy |
+2,695
| New | +$236K | ﹤0.01% | 1376 |
|